Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
7.11
-0.41 (-5.45%)
Feb 21, 2025, 4:00 PM EST - Market closed
Atara Biotherapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$25.70
Upside
+261.46%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 22, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $21 → $17 | Strong Buy | Maintains | $21 → $17 | +139.10% | Jan 17, 2025 |
| Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +251.62% | Dec 20, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 → $21 | Strong Buy | Maintains | $13 → $21 | +195.36% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 21, 2024 |
| Mizuho | Mizuho | Hold → Buy Upgrades $25 → $18 | Hold → Buy | Upgrades | $25 → $18 | +153.16% | Aug 16, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $13 | Strong Buy | Maintains | $13 | +82.84% | Aug 13, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $13 → $11 | Strong Sell | Maintains | $13 → $11 | +54.71% | Jul 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 22, 2024 |
| Stifel | Stifel | Hold Maintains $120 → $58 | Hold | Maintains | $120 → $58 | +708.72% | Apr 1, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $75 → $13 | Strong Sell | Maintains | $75 → $13 | +75.81% | Nov 10, 2023 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 9, 2023 |
| Mizuho | Mizuho | Strong Buy → Hold Downgrades $775 → $25 | Strong Buy → Hold | Downgrades | $775 → $25 | +251.62% | Nov 9, 2023 |
| Citigroup | Citigroup | Strong Sell Maintains $50 → $35 | Strong Sell | Maintains | $50 → $35 | +392.26% | Aug 21, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.